Latest Patents News

IPH Limited reported a 16.9% jump in net profit to $80.4 million for FY26, driven by strong Canadian growth and operational discipline, alongside a new CEO appointment and its inaugural sustainability report.

Mount Ridley Mines has lodged a provisional patent for its SelectroTM hydrometallurgical leach technology, demonstrating superior recoveries of rare earths, scandium, and gallium compared to conventional methods. The company is advancing testwork and commercial discussions to capitalise on the innovation.

Nimy Resources has confirmed extensive soil geochemistry anomalies for gold and base metals at its Mons Project in Western Australia, setting the stage for a detailed ground electromagnetic survey and maiden drilling.

ION Video has appointed two seasoned executives to its board and elevated Anthony Baker to Managing Director as it sharpens focus on scaling its patented video technology. Founder Finbar O’Hanlon steps back from the board to concentrate on innovation and expanding the company’s IP portfolio.

The Environmental Group Limited (ASX:EGL) posted flat revenue of $112 million for FY26 but saw a sharp 44.7% fall in EBITDA and a $6 million net loss, weighed down by operational disruptions, a major ERP system implementation, and a $3 million goodwill impairment.

Marquee Resources shareholders rejected key share issues tied to the Tungsten Mountain acquisition, prompting the company to scrap the deal and refocus capital on advancing and monetising its existing portfolio.

Mesoblast has treated 350 patients in its pivotal Phase 3 trial for rexlemestrocel-L, targeting chronic low back pain linked to degenerative disc disease, setting the stage for top-line results in mid-2027.

Image Resources NL’s CEO Patrick Mutz will resign at the end of August 2026, with Chair Winston Lee stepping in as Executive Chair during the leadership transition. The company continues to operate its Atlas project while exploring innovative synthetic rutile processing.

Amcor’s FY2026 results reflect the full impact of its 2025 Berry Global acquisition, with net sales soaring 57% to $23.5 billion and net income more than doubling to $1.1 billion. The company also announced a fiscal year-end change and a raised dividend.

Dimerix has secured full sponsorship of the US Investigational New Drug application for its Phase 2-ready kidney drug DMX-652, setting the stage for a clinical trial targeting acute kidney injury in late 2026.

Hazer Group and KBR have secured a paid pre-feasibility study with a leading Japanese power utility to explore large-scale deployment of methane pyrolysis technology, reinforcing Hazer's foothold in Japan's clean hydrogen market.

Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.